PMC:7600245 / 23194-23589
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T84 | 91-99 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T85 | 279-287 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T86 | 290-299 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T219 | 13-14 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T220 | 42-47 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T318 | 42-47 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T319 | 112-123 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T320 | 225-228 | Chemical | denotes | INF | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T321 | 359-378 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T322 | 359-368 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T323 | 369-378 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T324 | 384-387 | Chemical | denotes | INF | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T172 | 0-395 | Sentence | denotes | Importantly, a recent nonrandomized, open-label study in patients (n = 80) with non-severe COVID-19 showed that favipiravir (1600 mg orally twice daily on the first day, then 600 mg orally twice daily for thirteen days) with INF-α had significantly better therapeutic effects on SARS-CoV-2 infection, in terms of disease progression and viral clearance, than lopinavir/ritonavir with INF-α [73]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 638 | 225-230 | Gene | denotes | INF-α | Gene:3451 |
| 639 | 384-389 | Gene | denotes | INF-α | Gene:3451 |
| 642 | 57-65 | Species | denotes | patients | Tax:9606 |
| 651 | 112-123 | Chemical | denotes | favipiravir | MESH:C462182 |
| 652 | 359-378 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 661 | 91-99 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 662 | 284-299 | Disease | denotes | CoV-2 infection | MESH:C000657245 |